Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis

被引:96
|
作者
Moghddam, Seyedeh Raziyeh Mahdavi [1 ]
Ahad, Abdul [2 ]
Aqil, Mohd. [1 ]
Imam, Syed Sarim [3 ]
Sultana, Yasmin [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut, MB Rd, New Delhi 110062, India
[2] King Saud Univ, Coll Pharm, Dept Pharmaceut, POB 2457, Riyadh 11451, Saudi Arabia
[3] Glocal Univ, Glocal Sch Pharm, Saharanpur 247121, Uttar Pradesh, India
关键词
Diacerein; Topical; Niosomes; Box-Behnken design; Psoriasis; PLACEBO-CONTROLLED TRIAL; IN-VITRO EVALUATION; TRANSDERMAL DELIVERY; LIPID NANOPARTICLES; CHOLESTEROL; RELEASE; DRUG; BIOAVAILABILITY; OSTEOARTHRITIS; PREVALENCE;
D O I
10.1016/j.msec.2016.07.043
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
This research aimed towards the design of preparations of diacerein loaded cholesterol rich niosomes by employing a 3-factor, 3-level Box-Behnken design. Results indicated that Span 60 (90 mg) and cholesterol (10 mg), and 45 min of hydration time were found to be optimum for niosomes preparation. The prepared cholesterol rich niosomes were uniform and spherical in size. Optimized formulation F2 entrapped the drug with 83.02% efficiency in the cholesterol rich niosomes of the size 477.8 nm, presented the flux of 2.820 mu g/cm(2)/h, followed Higuchi model and non Fickian transport mechanism. The confocal laser scanning microscopy showed that niosomes accentuated the penetration of diacerein in the epidermal and dermal layer of rat skin. Stability study confirmed that cholesterol rich niosomes were stable for 2 months at 4 degrees C Concisely, the results showed that targeted diacerein delivery might be achieved using topically applied niosomes for enhanced treatment of psoriasis, which might eliminate adverse side effects associated with systemic exposure. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:789 / 797
页数:9
相关论文
共 50 条
  • [1] Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design
    Ajay B. Solanki
    Jolly R. Parikh
    Rajesh H. Parikh
    [J]. AAPS PharmSciTech, 8
  • [2] Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design
    Solanki, Ajay B.
    Parikh, Jolly R.
    Parikh, Rajesh H.
    [J]. AAPS PHARMSCITECH, 2007, 8 (04)
  • [3] Development of optimized formulation of liposome using 3-factor Box-Behnken Design
    Chouhan, Mahendra
    Sharma, Rajesh
    Dashora, Kamlesh
    [J]. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2021, 11 (03): : 7 - 13
  • [4] Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design
    Singh, Siddharth
    Awasthi, Rajendra
    [J]. ADMET AND DMPK, 2024, 12 (03): : 553 - 580
  • [5] Quality by Design and Optimization of Favipiravir Nanoparticles Using 3-Level Factorial Design by Box-Behnken Method
    Venugopal, Vijayan
    Meenachisundram, Sakthi Ganapathi
    Ramadoss, Karthikeyan
    Jayaprakash, Nandhini
    [J]. JOURNAL OF YOUNG PHARMACISTS, 2023, 15 (04) : 696 - 703
  • [6] Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability
    Zidan, Ahmed S.
    Ibrahim, Mahmoud Mokhtar
    El Megrab, Nagia A.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (09) : 1450 - 1459
  • [7] Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach
    Moghddam, Seyedeh Marziyeh Mahdavi
    Ahad, Abdul
    Aqil, Mohd.
    Imam, Syed Sarim
    Sultana, Yasmin
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (03) : 617 - 624
  • [8] Optimization of Paclitaxel Containing pH-Sensitive Liposomes By 3 Factor, 3 Level Box-Behnken Design
    Rane, Smita
    Prabhakar, Bala
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 75 (04) : 420 - 426
  • [9] Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design
    Salem, Heba F.
    Kharshoum, Rasha M.
    Sayed, Ossama M.
    Hakim, Lekaa F. Abdel
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (11) : 1871 - 1884
  • [10] Development and Optimization of Microemulsion Formulation using Box-Behnken Design for Enhanced Transdermal Delivery of Lornoxicam
    Naeem, Muhammad
    Rahman, Nisar Ur
    Khan, Jawad A.
    Sehti, Ayesha
    Nawaz, Zarqa
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (08): : 1196 - 1204